These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28032881)

  • 41. Case series of familial frontal fibrosing alopecia and a review of the literature.
    Navarro-Belmonte MR; Navarro-López V; Ramírez-Boscà A; Martínez-Andrés MA; Molina-Gil C; González-Nebreda M; Asín-Llorca M
    J Cosmet Dermatol; 2015 Mar; 14(1):64-9. PubMed ID: 25614294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expanding the spectrum of frontal fibrosing alopecia: a unifying concept.
    Chew AL; Bashir SJ; Wain EM; Fenton DA; Stefanato CM
    J Am Acad Dermatol; 2010 Oct; 63(4):653-60. PubMed ID: 20846567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frontal fibrosing alopecia: a review of eleven patients.
    Conde Fernandes I; Selores M; Machado S
    Eur J Dermatol; 2011; 21(5):750-2. PubMed ID: 21697058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
    Arias-Santiago S; Camacho-Martínez FM
    Actas Dermosifiliogr; 2016 Nov; 107(9):709-711. PubMed ID: 27436801
    [No Abstract]   [Full Text] [Related]  

  • 45. [Frontal fibrosing alopecia is a variant of lichen planopilaris].
    Gameza VA; Deleuran M
    Ugeskr Laeger; 2015 Jan; 177(2A):32-3. PubMed ID: 25612955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Finasteride adverse effects: An update].
    Carreño-Orellana N; Moll-Manzur C; Carrasco-Zuber JE; Álvarez-Véliz S; Berroeta-Mauriziano D; Porras-Kusmanic N
    Rev Med Chil; 2016 Dec; 144(12):1584-1590. PubMed ID: 28393993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frontal fibrosing alopecia in a postmenopausal woman.
    Lee WS; Hwang SM; Ahn SK
    Cutis; 1997 Dec; 60(6):299-300. PubMed ID: 9426971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride.
    Jung JY; Yeon JH; Choi JW; Kwon SH; Kim BJ; Youn SW; Park KC; Huh CH
    Int J Dermatol; 2014 Nov; 53(11):1351-7. PubMed ID: 24898559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up.
    Rossi A; Cantisani C; Scarnò M; Trucchia A; Fortuna MC; Calvieri S
    Dermatol Ther; 2011; 24(4):455-61. PubMed ID: 21910805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Steven Kossards postmenopausal frontal fibrosing alopecia (PFFA)--a therapeutic dilemma.
    Tchernev G; Tronnier M
    Akush Ginekol (Sofiia); 2010; 49(7):46-9. PubMed ID: 21428120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alopecia areata masquerading as frontal fibrosing alopecia.
    Kwong RA; Kossard S
    Australas J Dermatol; 2006 Feb; 47(1):63-6. PubMed ID: 16405488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frontal Fibrosing Alopecia in Men: Presentations in 12 Cases and a Review of the Literature.
    Ormaechea-Pérez N; López-Pestaña A; Zubizarreta-Salvador J; Jaka-Moreno A; Panés-Rodríguez A; Tuneu-Valls A
    Actas Dermosifiliogr; 2016 Dec; 107(10):836-844. PubMed ID: 27499250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frontal fibrosing alopecia - review of recent case reports and case series in PubMed.
    Valesky EM; Maier MD; Kippenberger S; Kaufmann R; Meissner M
    J Dtsch Dermatol Ges; 2018 Aug; 16(8):992-999. PubMed ID: 30117686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frontal fibrosing alopecia: a review of 60 cases.
    MacDonald A; Clark C; Holmes S
    J Am Acad Dermatol; 2012 Nov; 67(5):955-61. PubMed ID: 22503342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frontal Fibrosing Alopecia and Vitiligo: Coexistence or True Association?
    Katoulis AC; Diamanti K; Sgouros D; Liakou AI; Alevizou A; Bozi E; Damaskou V; Panayiotides I; Rigopoulos D
    Skin Appendage Disord; 2017 Jan; 2(3-4):152-155. PubMed ID: 28232924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.
    Rozner RN; Freites-Martinez A; Shapiro J; Geer EB; Goldfarb S; Lacouture ME
    Breast Cancer Res Treat; 2019 Feb; 174(1):15-26. PubMed ID: 30467659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
    Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Finasteride: middle-age cure-all for alopecia and benign prostatic hyperplasia?
    Federman DG
    Mayo Clin Proc; 2006 Feb; 81(2):267; author reply 267-8. PubMed ID: 16471089
    [No Abstract]   [Full Text] [Related]  

  • 59. Frontal Fibrosing Alopecia: A Retrospective Study of 75 Patients.
    Maldonado Cid P; Leis Dosil VM; Garrido Gutiérrez C; Salinas Moreno S; Thuissard Vasallo IJ; Andreu Vázquez C; Díaz Díaz RM
    Actas Dermosifiliogr (Engl Ed); 2020; 111(6):487-495. PubMed ID: 32417453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
    Drake L; Hordinsky M; Fiedler V; Swinehart J; Unger WP; Cotterill PC; Thiboutot DM; Lowe N; Jacobson C; Whiting D; Stieglitz S; Kraus SJ; Griffin EI; Weiss D; Carrington P; Gencheff C; Cole GW; Pariser DM; Epstein ES; Tanaka W; Dallob A; Vandormael K; Geissler L; Waldstreicher J
    J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.